Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18346-18353
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18346
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18346
Table 1 Zinc finger protein 139 expression in 108 gastric carcinoma patients according to clinicopathologic features
Clinical feature | Zinc finger protein 139 | P value | |
Positive (n) | Negative (n) | ||
Sex | 0.655 | ||
Male | 53 | 25 | |
Female | 19 | 11 | |
Age (yr) | 0.539 | ||
≥ 60 | 43 | 19 | |
< 60 | 29 | 17 | |
Tumor differentiation | 0.039 | ||
High/moderate | 39 | 27 | |
Poor/undifferentiated | 33 | 9 | |
Depth of invasion | 0.008 | ||
T1/T2 | 8 | 12 | |
T3/T4 | 64 | 24 | |
Lymphatic metastasis | 0.005 | ||
Positive | 53 | 16 | |
Negative | 19 | 20 | |
Nerve or blood vessel invasion | 0.033 | ||
Invaded | 29 | 7 | |
Not invaded | 43 | 29 | |
Tumor-node-metastasis stage | 0.002 | ||
I-II | 21 | 22 | |
III | 51 | 14 |
- Citation: Li Y, Zhao Q, Fan LQ, Wang LL, Tan BB, Leng YL, Liu Y, Wang D. Zinc finger protein 139 expression in gastric cancer and its clinical significance. World J Gastroenterol 2014; 20(48): 18346-18353
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18346.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18346